Core Insights - American Oncology Network (AON) showcased multiple research studies at the ASCO 2025 Annual Meeting, highlighting its commitment to advancing cancer care through evidence-based practices [1][6][8] - AON's participation reflects the organization's focus on innovation, collaboration, and improving patient outcomes in oncology [6][8] Research Highlights - AON physicians co-authored studies on various topics, including the safety and efficacy of ABBV-706 in neuroendocrine neoplasms, racial representation in clinical trials, and real-world outcomes of HER2 directed therapy in early-stage breast cancer [4][5] - Specific studies presented include: - "Bria-IMT + checkpoint inhibitor" in metastatic breast cancer [4] - "Impact of HLA matching on clinical outcomes" in advanced breast cancer [4] - "Real-world data on bispecific antibodies administration" in community oncology settings [5] - AON practices currently offer access to over 150 clinical trials, providing cutting-edge treatment options within local communities [7] Organizational Overview - AON is an alliance of over 290 providers across 21 states, founded in 2018, focusing on community oncology and innovative healthcare solutions [8] - The organization emphasizes value-based care, aiming to improve patient outcomes while reducing costs and expanding access to quality care [8] - AON is committed to promoting health equity and addressing disparities in cancer care [8]

Core Insights - American Oncology Network (AON) is expanding access to radioligand therapies (RLT) for prostate and neuroendocrine cancers, reflecting a commitment to innovative cancer care [1][5] - Over 300 treatments have been administered to nearly 70 patients across five AON partner practices, indicating strong demand and success for these therapies [1][5] Company Overview - AON is a rapidly growing community oncology network founded in 2018, representing over 290 providers across 21 states [6] - The organization focuses on value-based care, improving patient outcomes while reducing costs and expanding access to quality care [6] - AON aims to promote health equity by addressing disparities in cancer care and ensuring all patients have access to necessary treatments [6] Radioligand Therapies - AON now offers three FDA-approved radiopharmaceuticals: Pluvicto™, Xofigo, and Lutathera, targeting specific cancer types [2][3] - Radioligand therapy involves attaching a radioactive isotope to a targeting molecule, allowing for precise radiation delivery to cancer cells while minimizing damage to healthy tissue [2][3] Future Growth - AON anticipates continued growth in the utilization of radioligand therapies as more sites obtain the necessary infrastructure and regulatory approvals [5]

Company Overview - American Oncology Network (AON) is one of the fastest-growing community oncology networks in the United States, founded in 2018, representing over 290 providers across 21 states [6][7] - AON focuses on innovative healthcare solutions through a physician-led model, promoting value-based care that improves patient outcomes while reducing costs [7] Leadership Appointment - Joe Verschleiser has been appointed as the chief growth and performance officer of AON, bringing over a decade of experience in healthcare, including roles in operations, financial strategy, and mergers and acquisitions [2][3] - His previous role was president of the West Division at Unified Women's Healthcare, where he managed strategy and operations for over 200 physicians [3] Strategic Focus - In his new role, Verschleiser will lead growth strategy and performance optimization for AON partner practices, focusing on expansion and new business line opportunities [2] - AON aims to strengthen its national presence and support the long-term success of its partner practices through strategic initiatives [2][4] Commitment to Quality Care - AON is dedicated to expanding access to high-quality, affordable cancer care and addressing disparities in cancer care to promote health equity [4][7] - The organization provides comprehensive support and integrated services to enable physicians to focus on delivering the highest standard of care [7]

Sakeer Hussain, MD, was honored for his dedication to advancing cancer policy at national and state levels during ASCO's 2025 Advocacy Summit event COUNCIL BLUFFS, Iowa, May 14, 2025 (GLOBE NEWSWIRE) -- Sakeer Hussain, MD, a Board-certified medical oncologist at Heartland Oncology and Hematology, a partner practice of the American Oncology Network (AON), has been recognized as a 2025 Advocacy Champion by the Association for Clinical Oncology (ASCO). The distinction was announced during ASCO's annual Advocac ...

Core Insights - American Oncology Network (AON) has appointed Terri Casey as the new Chief Human Resources Officer (CHRO) to enhance leadership and talent development as the company continues to grow [1][2]. Company Overview - AON is one of the fastest-growing community oncology networks in the United States, founded in 2018, and currently represents over 290 providers across 21 states [5][7]. - The organization focuses on innovative healthcare solutions through a physician-led model, aiming to improve patient outcomes while reducing costs and expanding access to quality care [5][7]. Leadership Appointment - Terri Casey brings over 15 years of experience in human resources, particularly in the healthcare sector, and has held executive roles in various physician specialty practices [2][3]. - Her expertise includes partnering with executives to achieve financial goals and fostering a workplace culture that attracts and retains top talent [2][3]. Strategic Vision - Casey expressed her commitment to AON's mission of making cancer care affordable and accessible, emphasizing the importance of building a strong workplace culture and creating meaningful relationships [3]. - The evolving healthcare landscape presents new opportunities and challenges, which Casey's strategic HR leadership is expected to address effectively [3]. Commitment to Health Equity - AON is dedicated to promoting health equity by addressing disparities in cancer care, ensuring all patients have access to necessary care for optimal health outcomes [7].

Core Insights - American Oncology Network (AON) is participating in 14 speaking sessions at the 2025 Community Oncology Alliance (COA) Annual Conference, focusing on advocacy, innovation, and access in independent community oncology [1][2] Group 1: Conference Details - The conference will take place on April 29-30, 2025, in Orlando, Florida, under the theme "Empower & Advocate: Independent Community Oncology" [1] - AON leaders will discuss various topics including payer contracting, value-based care, patient advocacy, clinical trials, and mental health programs [2][4] Group 2: Leadership and Contributions - Stephen "Fred" Divers, MD, AON's chief medical officer, emphasizes the importance of local practices in delivering patient-centered care [2] - Alti Rahman, AON chief strategy and innovation officer, highlights the shared mission of AON and COA to protect and promote independent oncology [5] Group 3: AON's Support Services - AON provides comprehensive support services to independent oncology practices, including in-house pharmacy, lab services, and revenue-diversifying programs [5][7] - The organization aims to enable physicians to focus on high-quality care without reliance on hospital systems or third-party providers [5][7] Group 4: Commitment to Health Equity - AON is dedicated to promoting health equity by addressing disparities in cancer care and ensuring access to quality care for all patients [7]

Strategic Thyme Care partnership strengthens AON's leadership in value-based care innovation while improving patient experience and reducing costs FORT MYERS, Fla., April 22, 2025 (GLOBE NEWSWIRE) -- American Oncology Network (AON), one of the nation's fastest-growing community oncology networks, today announced strong results from the first performance period in the Centers for Medicare & Medicaid Innovation's (CMMI) Enhancing Oncology Model (EOM). AON practices participating in the program—in collaboratio ...

Core Insights - American Oncology Network (AON) announced the appointment of Anne Marie Rainey as a member of the Association of Cancer Care Centers' Board of Trustees, highlighting AON's commitment to leadership in oncology care [1][4]. Company Overview - AON is a rapidly growing community oncology network founded in 2018, representing over 290 providers across 21 states, focusing on innovative healthcare solutions and value-based care [5]. - The organization aims to improve patient outcomes while reducing costs and expanding access to quality care through a physician-led model [5][6]. Leadership and Initiatives - Anne Marie Rainey, as the director of value-based care at AON, manages quality initiatives and has a background in government quality reporting [3]. - Rainey expressed her commitment to advancing oncology education and advocacy for cancer patients through her role on the ACCC Board [4]. Association of Cancer Care Centers (ACCC) - ACCC is an education and advocacy organization for the cancer care community, consisting of over 45,000 professionals from 1,700 provider organizations [7]. - The organization adapts its resources to meet the evolving needs of oncology care teams, reflecting advancements in cancer treatment and care delivery [7].

Core Insights - MidAmerica Cancer Care (MACC) has opened a new medical oncology clinic in Kansas City, Kansas, enhancing cancer care for the local community [1][3] - The new clinic features private exam rooms, an infusion room, in-house lab and pathology services, and a specialty pharmacy for oral oncolytics [2] - MACC emphasizes a patient-first approach, providing personalized care and treatment plans tailored to individual needs [3][9] Company Overview - MACC is a community-based oncology practice established in 2019, dedicated to providing compassionate cancer care [9] - The practice operates with a team of six physicians and 16 advanced practitioners, focusing on treating the whole patient [10] - MACC has partnered with American Oncology Network (AON) to enhance patient care and expand service offerings [4][6] Partnership and Services - The partnership with AON allows MACC to provide additional services, including access to an in-house specialty pharmacy with home delivery options [4] - AON represents over 290 providers across 21 states, focusing on value-based care and improving patient outcomes [6][8] - AON is committed to health equity, addressing disparities in cancer care to ensure all patients have access to necessary treatments [8]

Company Overview - American Oncology Network, Inc. is a microcap healthcare stock trading on an OTC exchange, relatively unknown among analysts and investors [1] Analyst Background - Robert F. Abbott has been managing his family's investments since 1995 and has experience with options since 2010, focusing on covered calls and collars with long stocks [2]